Recurrent intracranial melanocytoma associated with a nevus of Ota.
Rutten
I
I
Department of Radiotherapy, Centre Hospitalier Universitaire de Liège, Sart Tilman, Belgium. irutten@chu.ulg.ac.be
Bolle
S
S
Kaschten
B
B
Stevenaert
A
A
Deneufbourg
J-M
JM
Deprez
M
M
D000328:Adult; D000951:Antigens, Neoplasm; D014408:Biomarkers, Tumor / Q000378:metabolism; D035262:Cranial Fossa, Anterior / Q000473:pathology; D005260:Female; D005625:Frontal Lobe / Q000378:metabolism / Q000473:pathology; D005911:Gliosis / Q000209:etiology / Q000473:pathology; D006801:Humans; D008544:Melanocytes / Q000473:pathology; D008545:Melanoma / Q000150:complications / Q000473:pathology* / Q000601:surgery; D058950:Melanoma-Specific Antigens; D008577:Meningeal Neoplasms / Q000150:complications / Q000473:pathology* / Q000601:surgery; D008578:Meninges / Q000473:pathology* / Q000503:physiopathology; D009361:Neoplasm Invasiveness / Q000473:pathology; D009363:Neoplasm Proteins / Q000378:metabolism; D009364:Neoplasm Recurrence, Local / Q000473:pathology* / Q000601:surgery; D009507:Nevus of Ota / Q000150:complications / Q000473:pathology*; D011878:Radiotherapy; D009418:S100 Proteins / Q000378:metabolism; D012878:Skin Neoplasms / Q000150:complications / Q000473:pathology*; D016896:Treatment Outcome
D000951:Antigens, Neoplasm; D014408:Biomarkers, Tumor; D058950:Melanoma-Specific Antigens; D009363:Neoplasm Proteins; D009418:S100 Proteins